New rules for new drugs: the challenge of AIDS to the regulatory process.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D001294:Attitude to Health; D002985:Clinical Protocols / Q000592:standards; D002986:Clinical Trials as Topic; D003657:Decision Making; D004345:Drug Industry / Q000331:legislation & jurisprudence; D015507:Drugs, Investigational; D004467:Economics; D026724:Ethical Review; D004989:Ethics; D017041:Ethics Committees; D028744:Ethics Committees, Research; D035082:Federal Government; D006076:Government; D033161:Government Regulation; D006291:Health Policy / Q000639:trends*; D006664:History; D006805:Human Experimentation; D006801:Humans; D007258:Informed Consent; D007391:International Cooperation; D038622:Internationality; D009316:National Institutes of Health (U.S.); D009936:Organizational Innovation; D010344:Patient Advocacy; D010361:Patients; D004364:Pharmaceutical Preparations; D010820:Physicians; D011057:Politics; D012106:Research / Q000592:standards; D012107:Research Design; D035842:Research Subjects; D012306:Risk; D018570:Risk Assessment; D015871:Scientific Misconduct; D012926:Social Control, Formal; D036302:Therapeutic Human Experimentation; D014481:United States; D014486:United States Food and Drug Administration / Q000458:organization & administration*
AIDS Coalition to Unleash Power (ACT UP); Biomedical and Behavioral Research; Health Care and Public Health; Legal Approach; National Institutes of Health